GROUP 2 PULMONARY HYPERTENSION
Clinical trials for GROUP 2 PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new GROUP 2 PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for GROUP 2 PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug targets double trouble: heart failure meets lung pressure
Disease control Recruiting nowThis study is testing an experimental drug called JK07 in people who have both heart failure and high blood pressure in their lungs. About 30 adults will receive the drug to check if it's safe and how their bodies process it. The main goal is to see if JK07 can be tolerated and h…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New procedure targets deadly lung pressure in heart failure
Disease control Recruiting nowThis early study is testing a new catheter-based procedure that aims to calm overactive nerves around the lung arteries. It is for people with heart failure who have also developed high blood pressure in their lungs, a condition with no approved treatments. The goal is to see if …
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: NA • Sponsor: Gradient Denervation Technologies • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC